Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 10, 2020 08:00 ET | Source: Applied Molecular Transport Inc.

Applied Molecular Transport Announces Publication of Preclinical Data Demonstrating Potential of Novel Oral IL-10 Biologic Therapeutic (AMT-101) for Inflammatory Diseases in The Journal of Immunology

- AMT-101 (oral fusion protein of hIL-10 and AMT carrier) rapidly and efficiently transports through intestinal epithelia in healthy and inflamed conditions to target local intestinal tissue - -...
September 22, 2020 08:00 ET | Source: Applied Molecular Transport Inc.

Applied Molecular Transport to Present at Jefferies Next Generation IBD Therapeutics Virtual Summit

SOUTH SAN FRANCISCO, Calif., Sept. 22, 2020 (GLOBE NEWSWIRE) -- Applied Molecular Transport (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood,...
August 27, 2020 08:00 ET | Source: Applied Molecular Transport Inc.

Applied Molecular Transport Announces First Patient Dosed in Phase 2 Study of Oral AMT-101 in Ulcerative Colitis

SOUTH SAN FRANCISCO, Calif., Aug. 27, 2020 (GLOBE NEWSWIRE) -- Applied Molecular Transport (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that the first patient...
August 11, 2020 16:00 ET | Source: Applied Molecular Transport Inc.

Applied Molecular Transport Reports Second Quarter 2020 Financial Results

-Company debuts with successful $177 million IPO -Plans to initiate three Phase 2 clinical trials for AMT-101 in 2020; anticipates top-line data readouts in 2H 2021 and 1H 2022 -On track to file...
August 05, 2020 08:00 ET | Source: Applied Molecular Transport Inc.

Applied Molecular Transport Named as One of Three Finalists for the Fierce Innovations Awards for AMT-101

SOUTH SAN FRANCISCO, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Applied Molecular Transport (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that AMT-101 has been...
June 09, 2020 16:05 ET | Source: Applied Molecular Transport Inc.

Applied Molecular Transport Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

SOUTH SAN FRANCISCO, Calif., June 09, 2020 (GLOBE NEWSWIRE) -- Applied Molecular Transport (Nasdaq: AMTI), a clinical-stage biopharmaceutical company, today announced the closing of its initial...
June 04, 2020 22:40 ET | Source: Applied Molecular Transport Inc.

Applied Molecular Transport Announces Pricing of Initial Public Offering

SOUTH SAN FRANCISCO, Calif., June 04, 2020 (GLOBE NEWSWIRE) -- Applied Molecular Transport (Nasdaq: AMTI), a clinical-stage biopharmaceutical company, today announced the pricing of its initial...
April 21, 2020 08:00 ET | Source: Applied Molecular Transport Inc.

Applied Molecular Transport Appoints Industry Veteran Shawn Cross as Chief Financial Officer and Promotes Bittoo Kanwar, M.D. to Chief Medical Officer

SOUTH SAN FRANCISCO, Calif., April 21, 2020 (GLOBE NEWSWIRE) -- Applied Molecular Transport (“AMT”), a clinical-stage biopharmaceutical company, today announced the appointment of Shawn Cross as the...